Cassava Sciences Inc - Asset Resilience Ratio

Latest as of March 2017: 11.92%

Cassava Sciences Inc (SAVA) has an Asset Resilience Ratio of 11.92% as of March 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check SAVA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$2.10 Million

Cash + Short-term Investments

Total Assets

$17.60 Million

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2017)

This chart shows how Cassava Sciences Inc's Asset Resilience Ratio has changed over time. See how leveraged is Cassava Sciences Inc's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Cassava Sciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Cassava Sciences Inc (SAVA) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$2.10 Million	11.92%
Total Liquid Assets	$2.10 Million	11.92%

Asset Resilience Insights

Moderate Liquidity: Cassava Sciences Inc has 11.92% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Cassava Sciences Inc Industry Peers by Asset Resilience Ratio

Compare Cassava Sciences Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Cassava Sciences Inc (2003–2017)

The table below shows the annual Asset Resilience Ratio data for Cassava Sciences Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2017-12-31	0.00%	$0.00	$10.83 Million	--
2016-12-31	10.87%	$2.10 Million	$19.30 Million	+8.38pp
2013-12-31	2.49%	$1.25 Million	$50.10 Million	-9.64pp
2012-12-31	12.13%	$6.90 Million	$56.86 Million	-13.12pp
2011-12-31	25.25%	$24.99 Million	$98.96 Million	-61.88pp
2010-12-31	87.13%	$86.43 Million	$99.19 Million	+10.23pp
2009-12-31	76.90%	$139.97 Million	$182.00 Million	+57.81pp
2008-12-31	19.10%	$36.94 Million	$193.44 Million	-37.98pp
2007-12-31	57.08%	$118.50 Million	$207.62 Million	-33.12pp
2006-12-31	90.19%	$188.01 Million	$208.46 Million	+35.98pp
2005-12-31	54.22%	$117.00 Million	$215.79 Million	-42.64pp
2004-12-31	96.86%	$98.02 Million	$101.19 Million	+15.63pp
2003-12-31	81.23%	$65.40 Million	$80.51 Million	--

pp = percentage points

About Cassava Sciences Inc

NASDAQ:SAVA USA Biotechnology

Market Cap

$58.21 Million

Market Cap Rank

#21404 Global

#4730 in USA

Share Price

$1.21

Change (1 day)

-6.23%

52-Week Range

$1.21 - $4.64

All Time High

$135.30